Xizang Weixinkang Pharmaceutical Co Ltd
603676
Company Profile
Business description
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
Contact
Yuanqu South Road
3rd Floor, Building 4, Industrial Center, No. 5
Zone B, Lhasa Economic and Technological
Development Zone, Tibet Autonomous Region
Lhasa850000
CHNT: +86 8916601760
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
763
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,389.10 | 43.40 | 0.46% |
| CAC 40 | 8,666.63 | 52.81 | 0.61% |
| DAX 40 | 26,202.35 | 201.04 | 0.77% |
| Dow JONES (US) | 54,085.88 | 907.47 | 1.71% |
| FTSE 100 | 10,879.38 | 21.68 | 0.20% |
| HKSE | 25,911.95 | 59.03 | 0.23% |
| NASDAQ | 26,584.99 | 671.10 | 2.59% |
| Nikkei 225 | 66,001.76 | 2,044.23 | 3.20% |
| NZX 50 Index | 13,964.69 | 61.23 | 0.44% |
| S&P 500 | 7,736.52 | 136.02 | 1.79% |
| S&P/ASX 200 | 9,211.60 | 35.10 | 0.38% |
| SSE Composite Index | 3,873.56 | 51.27 | 1.34% |